Published in Infect Immun on December 01, 1992
Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun (1994) 1.54
Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control. PLoS Med (2008) 1.37
Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines. Infect Immun (1994) 0.98
Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection. Clin Exp Immunol (2003) 0.90
Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma. Invest Ophthalmol Vis Sci (2010) 0.87
Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma. Infect Immun (1997) 0.83
Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13
A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods (1983) 4.39
Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med (1989) 4.25
Chlamydial infections. Annu Rev Med (1981) 3.94
High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1988) 3.55
Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun (1979) 3.39
Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34
Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial-conjunctivitis in guinea pigs. Proc Natl Acad Sci U S A (1986) 2.24
An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci (1982) 2.16
An animal model for cicatrizing trachoma. Invest Ophthalmol Vis Sci (1981) 1.44
Trachoma. Br Med Bull (1983) 1.18
Immunohistochemical study of the local inflammatory response to chlamydial ocular infection. Invest Ophthalmol Vis Sci (1986) 1.15
Immune responses and chlamydial infections. Br Med Bull (1983) 1.10
Changes in conjunctival lymphocyte populations induced by oral immunization with Chlamydia trachomatis. Curr Eye Res (1986) 0.90
Chlamydia-specific lymphocytes in conjunctiva during ocular infection: limiting dilution analysis. Reg Immunol (1991) 0.90
Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection. Infect Immun (1989) 0.87
A simple system for the assessment of trachoma and its complications. Bull World Health Organ (1987) 12.27
Blindness and visual impairment in southern Malawi. Bull World Health Organ (1986) 6.07
Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol (1987) 5.64
Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature (1972) 4.08
The ecology of trachoma: an epidemiological study in southern Mexico. Bull World Health Organ (1985) 3.91
Trachoma: evaluation of a new grading scheme in the United Republic of Tanzania. Bull World Health Organ (1987) 3.48
A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol (1992) 3.28
Age-standardization in epidemiological data. Int J Epidemiol (1994) 3.17
Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet (1995) 3.06
Clinical grading and the effects of scaling. Invest Ophthalmol Vis Sci (1991) 2.89
Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA (1986) 2.69
The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology (1998) 2.63
An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. J Clin Invest (1972) 2.61
The environment and the lens. Br J Ophthalmol (1980) 2.59
The epidemiology of dry eye in Melbourne, Australia. Ophthalmology (1998) 2.58
Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34
Cataract: how much surgery do we have to do? Br J Ophthalmol (2000) 2.34
Diabetic retinopathy: examination practices and referral patterns of general practitioners. Med J Aust (1996) 2.19
An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci (1982) 2.16
Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol (1989) 2.16
Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol (1998) 2.14
Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. Am J Epidemiol (1996) 2.03
Prevalence and causes of vision loss in central Tanzania. Int Ophthalmol (1991) 2.02
The excimer laser in Australia. Med J Aust (1992) 2.01
The epidemiology of cataract in Australia. Am J Ophthalmol (1999) 2.01
Age-specific causes of bilateral visual impairment. Arch Ophthalmol (2000) 1.98
Vision impairment predicts 5 year mortality. Br J Ophthalmol (2001) 1.98
Prevalence and risk factors of myopia in Victoria, Australia. Arch Ophthalmol (1999) 1.95
The epidemiology of trachoma in central Tanzania. Int J Epidemiol (1991) 1.93
Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project. Ophthalmology (2001) 1.90
Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol (2001) 1.88
An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science (1991) 1.86
Ocular exposure to UV-B in sunlight: the Melbourne visual impairment project model. Bull World Health Organ (1996) 1.83
Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol (2005) 1.82
Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun (1992) 1.77
Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol (1995) 1.76
Resuturing following penetrating keratoplasty: a retrospective analysis. Br J Ophthalmol (2008) 1.75
Subgroups of gamma-A immune globulins. Proc Soc Exp Biol Med (1966) 1.73
The prevalence of glaucoma among Eskimos of northwest Alaska. Arch Ophthalmol (1987) 1.72
A comparative histologic study of the fibrillin microfibrillar system in the lens capsule of normal subjects and subjects with Marfan syndrome. Invest Ophthalmol Vis Sci (1998) 1.71
Senile lens changes and diabetes in two population studies. Am J Ophthalmol (1981) 1.69
Methods for a population-based study of eye disease: the Melbourne Visual Impairment Project. Ophthalmic Epidemiol (1994) 1.69
The effect of prescription eyewear on ocular exposure to ultraviolet radiation. Am J Public Health (1986) 1.65
International ophthalmology strategic plan to preserve and restore vision-vision for the future. Am J Ophthalmol (2001) 1.65
The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology (2000) 1.64
The ocular dose of ultraviolet radiation from sunlight exposure. Photochem Photobiol (1985) 1.64
Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology (1993) 1.63
The effect of early cataracts on glare and contrast sensitivity. A pilot study. Arch Ophthalmol (1992) 1.61
Water availability and trachoma. Bull World Health Organ (1989) 1.61
Detection of hepatitis B virus DNA in tears by polymerase chain reaction. Arch Ophthalmol (1994) 1.57
Prevalence and predictors of undercorrected refractive errors in the Victorian population. Am J Ophthalmol (1999) 1.56
Perforating ocular fishhook injury. Arch Ophthalmol (1992) 1.54
Schizophrenia, psychotropic medication, and cataract. Ophthalmology (1999) 1.54
The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol (1989) 1.53
Epidemiology of ocular trauma in Australia. Ophthalmology (1999) 1.50
Pseudoexfoliation syndrome in Australian adults. Am J Ophthalmol (2000) 1.48
Knowledge, attitudes, and self care practices associated with age related eye disease in Australia. Br J Ophthalmol (1998) 1.46
Pterygium surgery in Victoria: a survey of ophthalmologists. Aust N Z J Ophthalmol (1998) 1.45
Recombination of heavy and light chains of human gamma-a-myeloma proteins: formation of hybrid molecules and configurational specificity. J Exp Med (1966) 1.45
Immunohistochemical localization of fibrillin in human ocular tissues. Relevance to the Marfan syndrome. Arch Ophthalmol (1995) 1.44
An animal model for cicatrizing trachoma. Invest Ophthalmol Vis Sci (1981) 1.44
The ocular dose of ultraviolet radiation to outdoor workers. Invest Ophthalmol Vis Sci (1988) 1.44
A systematic approach to the diagnosis and treatment of chronic conjunctivitis. Am J Ophthalmol (1990) 1.43
Epidemiology of corneal blindness in developing countries. Refract Corneal Surg (1992) 1.43
The epidemiology of trachoma in southern Malawi. Am J Trop Med Hyg (1988) 1.41
Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol (2000) 1.41
Management of alkali burns : an 11-year retrospective review. Ophthalmology (2000) 1.40
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med (1985) 1.39
Blindness and trachoma in South Australia. Aust N Z J Ophthalmol (1995) 1.39
Controlled study of the use of autologous serum in dry eye patients. Cornea (2001) 1.39
A comparison of participants with non-participants in a population-based epidemiologic study: the Melbourne Visual Impairment Project. Ophthalmic Epidemiol (1997) 1.38
Application of the verbal autopsy during a clinical trial. Soc Sci Med (1990) 1.38
Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med J Aust (2001) 1.38
Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology (2001) 1.38
Use of eye care services by people with diabetes: the Melbourne Visual Impairment Project. Br J Ophthalmol (1998) 1.37
Ocular and facial skin exposure to ultraviolet radiation in sunlight: a personal exposure model with application to a worker population. Health Phys (1991) 1.37
Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project. Br J Ophthalmol (2000) 1.34
Cellular killing of microfilariae of Onchocerca volvulus: eosinophil and neutrophil-mediated immune serum-dependent destruction. J Immunol (1981) 1.34
The epidemiology of cataract: a review of the literature. Ophthalmic Epidemiol (1995) 1.33
Characterization of the serum and secretory immune systems of the cow and sheep. J Immunol (1969) 1.33
Community-based recruitment strategies for a longitudinal interventional study: the VECAT experience. J Clin Epidemiol (2000) 1.30
Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection. Mol Microbiol (2001) 1.30
Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer (1990) 1.29
Experimental viral-induced congenital encephalopathies. I. Pathology of hydranencephaly and porencephaly caused by bluetongue vaccine virus. Lab Invest (1971) 1.28
A simplified cataract grading system. Ophthalmic Epidemiol (2002) 1.28
Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br J Ophthalmol (2000) 1.28
Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. Ophthalmology (1989) 1.27
Attributable risk estimates for cataract to prioritize medical and public health action. Invest Ophthalmol Vis Sci (2000) 1.26
Cigarette smoking and risk of nuclear cataracts. Arch Ophthalmol (1989) 1.25
Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabet Med (2013) 1.25
Chlamydia and associated arthritis. Curr Opin Rheumatol (2000) 1.25
Oral immunization with chlamydial major outer membrane protein (MOMP). Invest Ophthalmol Vis Sci (1988) 1.25
Corneal epithelial basement membrane changes in diabetes. Invest Ophthalmol Vis Sci (1981) 1.25
A case report of fowl plague keratoconjunctivitis. Br J Ophthalmol (1977) 1.24
Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project. Br J Ophthalmol (2006) 1.23
Cell-mediated immune responses in human infection with Onchocerca volvulus. J Immunol (1988) 1.22